Literature DB >> 943520

Oral ingestion of narcotic analgesics by rats.

D E McMillan, J D Leander, T W Wilson, S C Wallace, T Fix, S Redding, R T Turk.   

Abstract

Rats drank solutions of narcotic analgesics as the only drinking fluid available in their cages. Relative to their daily water intake before the drug solutions were introduced, the rats drank more etonitazene solution, less methadone solution, and about the same volume of morphine, meperidine and levorphanol solution as water, although some rats would not drink the higher concentrations of morphine (1.0 mg/ml), levorphanol (1.0 mg/ml) and methadone (1.0 mg/ml). When naloxone (1.0 mg/kg) was administered after 12 days of drinking the drug solutions, the severity of the abstinence syndromes based on scoring of symptoms and on weight loss was morphine greater than or equal to etonitazine greater than levorphanol greater than meperidine greater than methadone. The animals showing the most severe syndrome after naloxone usually consumed more drug solution than usual during the next 24 hours, so that body weights were normal at the end of the 24-hour period. Nonprecipitated abstinence was also studied in these rats by replacing the drug solutions with water 3 to 5 days after the naloxone injection. Rats that had been drinking morphine, etonitazene and levorphanol lost weight for 2 or 3 days and then began to regain their lost weight. In contrast, rats which had been switched from methadone and meperidine solutions to water gained weight rapidly. Morphine and etonitazene drinkers which had been switched to water drank a lesser volume of water than they had been drinking of drug solution whereas some ex-methadone drinkers drank more water.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 943520

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Aversiveness of oral methadone in rats.

Authors:  R E Chipkin; J A Rosecrans
Journal:  Psychopharmacology (Berl)       Date:  1978-05-31       Impact factor: 4.530

2.  Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in rats.

Authors:  J U Adams; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Interoceptive conditioning through repeated suppression of morphine-abstinence. II. Relapse-testing.

Authors:  D B Miller; J A Dougherty; A Wikler
Journal:  Pavlov J Biol Sci       Date:  1979 Jul-Sep

4.  Orally delivered methadone as a reinforcer in rhesus monkeys.

Authors:  R B Stewart; J Grabowski; N S Wang; R A Meisch
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

5.  Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat.

Authors:  S L Lightman; W S Young
Journal:  J Physiol       Date:  1988-09       Impact factor: 5.182

6.  Production of tolerance and physical dependence in the rat by simple administration of morphine in drinking water.

Authors:  A A Badawy; C M Evans; M Evans
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

7.  Contributions of taste factors and gender to opioid preference in C57BL and DBA mice.

Authors:  M L Forgie; B L Beyerstein; B K Alexander
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 8.  Are astroglial cells involved in morphine tolerance?

Authors:  L Rönnbäck; E Hansson
Journal:  Neurochem Res       Date:  1988-02       Impact factor: 3.996

9.  Morphine withdrawal dramatically reduces lymphocytes in morphine-dependent macaques.

Authors:  Michael R Weed; Lucy M Carruth; Robert J Adams; Nancy A Ator; Robert D Hienz
Journal:  J Neuroimmune Pharmacol       Date:  2006-07-14       Impact factor: 4.147

10.  Schedule-controlled behavior in the morphine-dependent and post-dependent rat.

Authors:  L S Brady; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.